606
Views
112
CrossRef citations to date
0
Altmetric
Review

Exosome mimetics: a novel class of drug delivery systems

, , , &
Pages 1525-1541 | Published online: 16 Mar 2012

References

  • WolfPThe nature and significance of platelet products in human plasmaBr J Haematol19671332692886025241
  • CrawfordNThe presence of contractile proteins in platelet microparticles isolated from human and animal platelet-free plasmaBr J Haematol197121153694254312
  • DoonanFCotterTGMorphological assessment of apoptosisMethods200844320020418314050
  • HristovMErlWLinderSWeberPCApoptotic bodies from endothelial cells enhance the number and initiate the differentiation of human endothelial progenitor cells in vitroBlood200410492761276615242875
  • XieYBaiOYuanJTumor apoptotic bodies inhibit CTL responses and antitumor immunity via membrane-bound transforming growth factor-beta1 inducing CD8+ T-cell anergy and CD4+ Tr1 cell responsesCancer Res200969197756776619789353
  • ClineAMRadicMZApoptosis, subcellular particles, and autoimmunityClin Immunol2004112217518215240161
  • TheryCOstrowskiMSeguraEMembrane vesicles as conveyors of immune responsesNat Rev Immunol20099858159319498381
  • SchillerMBekeredjian-DingIHeyderPBlankNHoADLorenzHMAutoantigens are translocated into small apoptotic bodies during early stages of apoptosisCell Death Differ200815118319117932498
  • GregoryCDPoundJDMicroenvironmental influences of apoptosis in vivo and in vitroApoptosis20101591029104920237956
  • Muralidharan-ChariVClancyJWSedgwickAD’Souza-SchoreyCMicrovesicles: mediators of extracellular communication during cancer progressionJ Cell Sci2010123Pt 101603161120445011
  • PilzerDGasserOMoskovichOSchifferliJAFishelsonZEmission of membrane vesicles: roles in complement resistance, immunity and cancerSpringer Semin Immunopathol200527337538716189651
  • SheddenKXieXTChandaroyPChangYTRosaniaGRExpulsion of small molecules in vesicles shed by cancer cells: association with gene expression and chemosensitivity profilesCancer Res200363154331433712907600
  • SekulaMJanawaGStankiewiczEStepienEEndothelial microparticle formation in moderate concentrations of homocysteine and methionine in vitroCell Mol Biol Lett2011161697821161416
  • ShantsilaEKamphuisenPWLipGYCirculating microparticles in cardiovascular disease: implications for atherogenesis and atherothrombosisJ Thromb Haemost20108112358236820695980
  • Antwi-BaffourSKholiaSAryeeYKHuman plasma membrane-derived vesicles inhibit the phagocytosis of apoptotic cells – possible role in SLEBiochem Biophys Res Commun2010398227828320599722
  • ObregonCRothen-RutishauserBGitahiSKGehrPNicodLPExovesicles from human activated dendritic cells fuse with resting dendritic cells, allowing them to present alloantigensAm J Pathol200616962127213617148675
  • HugelBMartinezMCKunzelmannCFreyssinetJMMembrane microparticles: two sides of the coinPhysiology (Bethesda)200520222715653836
  • BuckiRBachelot-LozaCZachowskiAGiraudFSulpiceJCCalcium induces phospholipid redistribution and microvesicle release in human erythrocyte membranes by independent pathwaysBiochemistry1998374415383153919799499
  • GonzalezLJGibbonsEBaileyRWThe influence of membrane physical properties on microvesicle release in human erythrocytesPMC Biophys200921719703298
  • SalzerUHinterdorferPHungerUBorkenCProhaskaRCa(++)-dependent vesicle release from erythrocytes involves stomatin-specific lipid rafts, synexin (annexin VII), and sorcinBlood20029972569257711895795
  • CrawfordSDiamondDBrustolonLPenarretaREffect of increased extracellular ca on microvesicle production and tumor spheroid formationCancer Microenviron2010419310321505564
  • AharonATamariTBrennerBMonocyte-derived microparticles and exosomes induce procoagulant and apoptotic effects on endothelial cellsThromb Haemost2008100587888518989533
  • ThomasLMSalterRDActivation of macrophages by P2X7-induced microvesicles from myeloid cells is mediated by phospholipids and is partially dependent on TLR4J Immunol201018563740374920709956
  • WileyJSSluyterRGuBJStokesLFullerSJThe human P2X7 receptor and its role in innate immunityTissue Antigens201178532133221988719
  • RecordMSubraCSilvente-PoirotSPoirotMExosomes as intercellular signalosomes and pharmacological effectorsBiochem Pharmacol201181101171118221371441
  • SimonsMRaposoGExosomes – vesicular carriers for intercellular communicationCurr Opin Cell Biol200921457558119442504
  • TaylorDDGercel-TaylorCExosomes/microvesicles: mediators of cancer-associated immunosuppressive microenvironmentsSemin Immunopathol201133544145421688197
  • SahooSKlychkoEThorneTExosomes from human CD34(+) stem cells mediate their proangiogenic paracrine activityCirc Res2011109772472821835908
  • SokolovaVLudwigAKHornungSCharacterisation of exosomes derived from human cells by nanoparticle tracking analysis and scanning electron microscopyColloids Surf B Biointerfaces201187114615021640565
  • SimpsonRJJensenSSLimJWProteomic profiling of exosomes: current perspectivesProteomics20088194083409918780348
  • TheryCDubanLSeguraEVeronPLantzOAmigorenaSIndirect activation of naive CD4+ T cells by dendritic cell-derived exosomesNat Immunol20023121156116212426563
  • MartinezMCAndriantsitohainaRMicroparticles in angiogenesis: therapeutic potentialCirc Res2011109111011921700952
  • AharonABrennerBMicroparticles, thrombosis and cancerBest Pract Res Clin Haematol2009221616919285273
  • ChoJAParkHLimEHExosomes from ovarian cancer cells induce adipose tissue-derived mesenchymal stem cells to acquire the physical and functional characteristics of tumor-supporting myofibroblastsGynecol Oncol2011123237938621903249
  • Baj-KrzyworzekaMMajkaMPraticoDPlatelet-derived microparticles stimulate proliferation, survival, adhesion, and chemotaxis of hematopoietic cellsExp Hematol200230545045912031651
  • Al-NedawiKMeehanBKerbelRSAllisonACRakJEndothelial expression of autocrine VEGF upon the uptake of tumor-derived microvesicles containing oncogenic EGFRProc Natl Acad Sci U S A2009106103794379919234131
  • RatajczakJWysoczynskiMHayekFJanowska-WieczorekARatajczakMZMembrane-derived microvesicles: important and underappreciated mediators of cell-to-cell communicationLeukemia20062091487149516791265
  • Del CondeIShrimptonCNThiagarajanPLopezJATissue-factor-bearing microvesicles arise from lipid rafts and fuse with activated platelets to initiate coagulationBlood200510651604161115741221
  • TianTWangYWangHZhuZXiaoZVisualizing of the cellular uptake and intracellular trafficking of exosomes by live-cell microscopyJ Cell Biochem2010111248849620533300
  • SarkarAMitraSMehtaSRaicesRWewersMDMonocyte derived microvesicles deliver a cell death message via encapsulated caspase-1PLoS One200949e714019779610
  • ValadiHEkstromKBossiosASjostrandMLeeJJLotvallJOExosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cellsNat Cell Biol20079665465917486113
  • MontecalvoALarreginaATShufeskyWJMechanism of transfer of functional microRNAs between mouse dendritic cells via exosomesBlood2012119375676622031862
  • ArroyoJDChevilletJRKrohEMArgonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasmaProc Natl Acad Sci U S A2011108125003500821383194
  • TurchinovichAWeizLLangheinzABurwinkelBCharacterization of extracellular circulating microRNANucleic Acids Res201139167223723321609964
  • GuesciniMGenedaniSStocchiVAgnatiLFAstrocytes and glioblastoma cells release exosomes carrying mtDNAJ Neural Transm201011711419680595
  • GuesciniMGuidolinDValloraniLC2C12 myoblasts release micro-vesicles containing mtDNA and proteins involved in signal transductionExp Cell Res2010316121977198420399774
  • MitchellPSParkinRKKrohEMCirculating microRNAs as stable blood-based markers for cancer detectionProc Natl Acad Sci U S A200810530105131051818663219
  • SkogJWurdingerTvan RijnSGlioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkersNat Cell Biol200810121470147619011622
  • PegtelDMCosmopoulosKThorley-LawsonDAFunctional delivery of viral miRNAs via exosomesProc Natl Acad Sci U S A2010107146328633320304794
  • CastanottoDRossiJJThe promises and pitfalls of RNA-interference-based therapeuticsNature2009457722842643319158789
  • BaigudeHRanaTMDelivery of therapeutic RNAi by nanovehiclesChembiochem200910152449245419688785
  • van den BoornJGSchleeMCochCHartmannGSiRNA delivery with exosome nanoparticlesNat Biotechnol201129432532621478846
  • Alvarez-ErvitiLSeowYYinHBettsCLakhalSWoodMJDelivery of siRNA to the mouse brain by systemic injection of targeted exosomesNat Biotechnol201129434134521423189
  • DelcayreAEstellesASperindeJExosome display technology: applications to the development of new diagnostics and therapeuticsBlood Cells Mol Dis200535215816816087368
  • OtzenDEBlansKWangHGilbertGERasmussenJTLactadherin binds to phosphatidylserine-containing vesicles in a two-step mechanism sensitive to vesicle size and compositionBiochim Biophys Acta2012181841019102721920348
  • ZeelenbergISOstrowskiMKrumeichSTargeting tumor antigens to secreted membrane vesicles in vivo induces efficient antitumor immune responsesCancer Res20086841228123518281500
  • HartmanZCWeiJGlassOKIncreasing vaccine potency through exosome antigen targetingVaccine201129509361936722001882
  • RountreeRBMandlSJNachtweyJMExosome targeting of tumor antigens expressed by cancer vaccines can improve antigen immunogenicity and therapeutic efficacyCancer Res201171155235524421670078
  • EscudierBDorvalTChaputNVaccination of metastatic melanoma patients with autologous dendritic cell (DC) derived-exosomes: results of the first phase I clinical trialJ Transl Med2005311015740633
  • MorseMAGarstJOsadaTA phase I study of dexosome immunotherapy in patients with advanced non-small cell lung cancerJ Transl Med200531915723705
  • SunDZhuangXXiangXA novel nanoparticle drug delivery system: the anti-inflammatory activity of curcumin is enhanced when encapsulated in exosomesMol Ther20101891606161420571541
  • ZhuangXXiangXGrizzleWTreatment of brain inflammatory diseases by delivering exosome encapsulated anti-inflammatory drugs from the nasal region to the brainMol Ther201119101769177921915101
  • OgawaraKRotsMGKokRJA novel strategy to modify adenovirus tropism and enhance transgene delivery to activated vascular endothelial cells in vitro and in vivoHum Gene Ther200415543344315144574
  • KimWJKimSWEfficient siRNA delivery with non-viral polymeric vehiclesPharm Res200926365766619015957
  • SinghaKNamgungRKimWJPolymers in small-interfering RNA deliveryNucleic Acid Ther201121313314721749290
  • ClaytonAHarrisCLCourtJMasonMDMorganBPAntigen-presenting cell exosomes are protected from complement-mediated lysis by expression of CD55 and CD59Eur J Immunol200333252253112645951
  • MeckesDGJrRaab-TraubNMicrovesicles and viral infectionJ Virol20118524128441285421976651
  • CamussiGDeregibusMCBrunoSGrangeCFonsatoVTettaCExosome/microvesicle-mediated epigenetic reprogramming of cellsAm J Cancer Res2011119811021969178
  • ChenTSArslanFYinYEnabling a robust scalable manufacturing process for therapeutic exosomes through oncogenic immortalization of human ESC-derived MSCsJ Transl Med201194721513579
  • PuriALoomisKSmithBLipid-based nanoparticles as pharmaceutical drug carriers: from concepts to clinicCrit Rev Ther Drug Carrier Syst200926652358020402623
  • FenskeDBCullisPRLiposomal nanomedicinesExpert Opin Drug Deliv200851254418095927
  • MathivananSSimpsonRJExoCarta: a compendium of exosomal proteins and RNAProteomics20099214997500019810033
  • MathivananSFahnerCJReidGESimpsonRJExoCarta 2012: database of exosomal proteins, RNA and lipidsNucleic Acids Res201240Database issueD1241124421989406
  • SubraCGrandDLaulagnierKExosomes account for vesicle-mediated transcellular transport of activatable phospholipases and prostaglandinsJ Lipid Res20105182105212020424270
  • LaulagnierKMottaCHamdiSMast cell- and dendritic cell-derived exosomes display a specific lipid composition and an unusual membrane organizationBiochem J2004380Pt 116117114965343
  • WubboltsRLeckieRSVeenhuizenPTProteomic and biochemical analyses of human B cell-derived exosomes. Potential implications for their function and multivesicular body formationJ Biol Chem200327813109631097212519789
  • AlonsoRMazzeoCRodriguezMCDiacylglycerol kinase alpha regulates the formation and polarisation of mature multivesicular bodies involved in the secretion of Fas ligand-containing exosomes in T lymphocytesCell Death Differ20111871161117321252909
  • WhiteIJBaileyLMAghakhaniMRMossSEFutterCEEGF stimulates annexin 1-dependent inward vesiculation in a multivesicular endosome subpopulationEMBO J200625111216052208
  • SubraCLaulagnierKPerretBRecordMExosome lipidomics unravels lipid sorting at the level of multivesicular bodiesBiochimie200789220521217157973
  • RothSLWhittakerGRPromotion of vesicular stomatitis virus fusion by the endosome-specific phospholipid bis(monoacylglycero)phosphate (BMP)FEBS Lett2011585686586921333650
  • ZaitsevaEYangSTMelikovKPourmalSChernomordikLVDengue virus ensures its fusion in late endosomes using compartment-specific lipidsPLoS Pathog2010610e100113120949067
  • Le BlancILuyetPPPonsVEndosome-to-cytosol transport of viral nucleocapsidsNat Cell Biol20057765366415951806
  • VidalMSainte-MarieJPhilippotJRBienvenueAAsymmetric distribution of phospholipids in the membrane of vesicles released during in vitro maturation of guinea pig reticulocytes: evidence precluding a role for “aminophospholipid translocase”J Cell Physiol198914034554622777884
  • NeedhamDNunnRSElastic deformation and failure of lipid bilayer membranes containing cholesterolBiophys J199058499710092249000
  • RamstedtBSlotteJPMembrane properties of sphingomyelinsFEBS Lett20025311333712401199
  • Abi-RizkGBessonFInteractions of Triton X-100 with sphingomyelin and phosphatidylcholine monolayers: influence of the cholesterol contentColloids Surf B Biointerfaces200866216316718644701
  • DrummondDCMeyerOHongKKirpotinDBPapahadjopoulosDOptimizing liposomes for delivery of chemotherapeutic agents to solid tumorsPharmacol Rev199951469174310581328
  • RodriguezMAPytlikRKozakTVincristine sulfate liposomes injection (Marqibo) in heavily pretreated patients with refractory aggressive non-Hodgkin lymphoma: report of the pivotal phase 2 studyCancer2009115153475348219536896
  • BoehlkeLWinterJNSphingomyelin/cholesterol liposomal vincristine: a new formulation for an old drugExpert Opin Biol Ther20066440941516548767
  • AllenTMAustinGAChonnALinLLeeKCUptake of liposomes by cultured mouse bone marrow macrophages: influence of liposome composition and sizeBiochim Biophys Acta19911061156641995057
  • AllenTMChonnALarge unilamellar liposomes with low uptake into the reticuloendothelial systemFEBS Lett1987223142463666140
  • YokoyamaSTakedaTTsunodaTOhtaYImuraTAbeMMembrane properties of mixed dipalmitoylphosphatidylglycerol/ganglioside GM3 liposomes in the presence of bovine serum albuminColloids Surf B Biointerfaces2003272–3141146
  • SchuttersKReutelingspergerCPhosphatidylserine targeting for diagnosis and treatment of human diseasesApoptosis20101591072108220440562
  • AllenTMWilliamsonPSchlegelRAPhosphatidylserine as a determinant of reticuloendothelial recognition of liposome models of the erythrocyte surfaceProc Natl Acad Sci U S A19888521806780713186707
  • PittoniVValesiniGThe clearance of apoptotic cells: implications for autoimmunityAutoimmun Rev20021315416112849009
  • MorelOJeselLFreyssinetJMTotiFCellular mechanisms underlying the formation of circulating microparticlesArterioscler Thromb Vasc Biol2011311152621160064
  • JeongJConboyIMPhosphatidylserine directly and positively regulates fusion of myoblasts into myotubesBiochem Biophys Res Commun2011414191321910971
  • WuZNakanishiHPhosphatidylserine-containing liposomes: potential pharmacological interventions against inflammatory and immune diseases through the production of prostaglandin E(2) after uptake by myeloid derived phagocytesArch Immunol Ther Exp (Warsz)201159319520121479802
  • MaxfieldFRMcGrawTEEndocytic recyclingNat Rev Mol Cell Biol20045212113215040445
  • ChernomordikLVKozlovMMProtein-lipid interplay in fusion and fission of biological membranesAnnu Rev Biochem20037217520714527322
  • PapahadjopoulosDNirSDuzgunesNMolecular mechanisms of calcium-induced membrane fusionJ Bioenerg Biomembr19902221571792139437
  • HafezIMCullisPRRoles of lipid polymorphism in intracellular deliveryAdv Drug Deliv Rev2001472–313914811311989
  • Al-NedawiKMeehanBMicallefJIntercellular transfer of the oncogenic receptor EGFRvIII by microvesicles derived from tumour cellsNat Cell Biol200810561962418425114
  • MeckesDGJrShairKHMarquitzARKungCPEdwardsRHRaab-TraubNHuman tumor virus utilizes exosomes for intercellular communicationProc Natl Acad Sci U S A201010747203702037521059916
  • MannoSTakakuwaYMohandasNIdentification of a functional role for lipid asymmetry in biological membranes: Phosphatidylserine-skeletal protein interactions modulate membrane stabilityProc Natl Acad Sci U S A20029941943194811830646
  • ParoliniIFedericiCRaggiCMicroenvironmental pH is a key factor for exosome traffic in tumor cellsJ Biol Chem200928449342113422219801663
  • NiemelaPSOllilaSHyvonenMTKarttunenMVattulainenIAssessing the nature of lipid raft membranesPLoS Comput Biol200732e3417319738
  • AimonSManziJSchmidtDPoveda LarrosaJABassereauPToombesGEFunctional reconstitution of a voltage-gated potassium channel in giant unilamellar vesiclesPLoS One2011610e2552921998666
  • ErbEMTangemannKBohrmannBMullerBEngelJIntegrin alphaIIb beta3 reconstituted into lipid bilayers is nonclustered in its activated state but clusters after fibrinogen bindingBiochemistry19973624739574029200686
  • StreicherPNassoyPBarmannMIntegrin reconstituted in GUVs: a biomimetic system to study initial steps of cell spreadingBiochim Biophys Acta20091788102291230019665445
  • ZhengMFangHTsuruokaTTsujiTSasakiTHakomoriSRegulatory role of GM3 ganglioside in alpha 5 beta 1 integrin receptor for fibronectin-mediated adhesion of FUA169 cellsJ Biol Chem19932683221722228420989
  • VarnierAKermarrecFBlesneacIA simple method for the reconstitution of membrane proteins into giant unilamellar vesiclesJ Membr Biol20102331–3859220135103
  • RaimondoFMorosiLChinelloCMagniFPittoMAdvances in membranous vesicle and exosome proteomics improving biological understanding and biomarker discoveryProteomics201111470972021241021
  • TheryCRegnaultAGarinJMolecular characterization of dendritic cell-derived exosomes. Selective accumulation of the heat shock protein hsc73J Cell Biol1999147359961010545503
  • EscolaJMKleijmeerMJStoorvogelWGriffithJMYoshieOGeuzeHJSelective enrichment of tetraspan proteins on the internal vesicles of multivesicular endosomes and on exosomes secreted by human B-lymphocytesJ Biol Chem19982733220121201279685355
  • AtaySGercel-TaylorCKesimerMTaylorDDMorphologic and proteomic characterization of exosomes released by cultured extravillous trophoblast cellsExp Cell Res201131781192120221276792
  • HemlerMETetraspanin functions and associated microdomainsNat Rev Mol Cell Biol200561080181116314869
  • HemlerMETargeting of tetraspanin proteins – potential benefits and strategiesNat Rev Drug Discov20087974775818758472
  • MiyadoKYamadaGYamadaSRequirement of CD9 on the egg plasma membrane for fertilizationScience2000287545132132410634791
  • TachibanaIHemlerMERole of transmembrane 4 superfamily (TM4SF) proteins CD9 and CD81 in muscle cell fusion and myotube maintenanceJ Cell Biol1999146489390410459022
  • MartinFRothDMJansDATetraspanins in viral infections: a fundamental role in viral biology?J Virol20057917108391085116103137
  • Gordon-AlonsoMYanez-MoMBarreiroOTetraspanins CD9 and CD81 modulate HIV-1-induced membrane fusionJ Immunol200617785129513717015697
  • TakedaYTachibanaIMiyadoKTetraspanins CD9 and CD81 function to prevent the fusion of mononuclear phagocytesJ Cell Biol2003161594595612796480
  • ParthasarathyVMartinFHigginbottomADistinct roles for tetraspanins CD9, CD63 and CD81 in the formation of multinucleated giant cellsImmunology2009127223724819489128
  • MantegazzaARBarrioMMMoutelSCD63 tetraspanin slows down cell migration and translocates to the endosomal-lysosomal-MIICs route after extracellular stimuli in human immature dendritic cellsBlood200410441183119015130945
  • NazarenkoIRanaSBaumannACell surface tetraspanin Tspan8 contributes to molecular pathways of exosome-induced endothelial cell activationCancer Res20107041668167820124479
  • HemlerMETetraspanin proteins mediate cellular penetration, invasion, and fusion events and define a novel type of membrane microdomainAnnu Rev Cell Dev Biol20031939742214570575
  • ZollerMTetraspanins: push and pull in suppressing and promoting metastasisNat Rev Cancer200991405519078974
  • van DommelenSMVaderPLakhalSMicrovesicles and exosomes: opportunities for cell-derived membrane vesicles in drug deliveryJ Control Release11252011 [Epub ahead of print.]
  • BarczykMCarracedoSGullbergDIntegrinsCell Tissue Res2010339126928019693543
  • CampbellIDHumphriesMJIntegrin structure, activation, and interactionsCold Spring Harb Perspect Biol201133a00499421421922
  • HakulinenJSankkilaLSugiyamaNLehtiKKeski-OjaJSecretion of active membrane type 1 matrix metalloproteinase (MMP-14) into extracellular space in microvesicular exosomesJ Cell Biochem200810551211121818802920
  • WeltonJLKhannaSGilesPJProteomics analysis of bladder cancer exosomesMol Cell Proteomics2010961324133820224111
  • RieuSGeminardCRabesandratanaHSainte-MarieJVidalMExosomes released during reticulocyte maturation bind to fibronectin via integrin alpha4beta1Eur J Biochem2000267258359010632729
  • ClaytonATurkesADewittSSteadmanRMasonMDHallettMBAdhesion and signaling by B cell-derived exosomes: the role of integrinsFASEB J200418997797915059973
  • SeguraMMGarnierADi FalcoMRIdentification of host proteins associated with retroviral vector particles by proteomic analysis of highly purified vector preparationsJ Virol20088231107111718032515
  • TemmingKSchiffelersRMMolemaGKokRJRGD-based strategies for selective delivery of therapeutics and imaging agents to the tumour vasculatureDrug Resist Updat20058638140216309948
  • MeineckeRMeyerBDetermination of the binding specificity of an integral membrane protein by saturation transfer difference NMR: RGD peptide ligands binding to integrin alphaIIbbeta3J Med Chem200144193059306511543674
  • ClaasenBAxmannMMeineckeRMeyerBDirect observation of ligand binding to membrane proteins in living cells by a saturation transfer double difference (STDD) NMR spectroscopy method shows a significantly higher affinity of integrin alpha(IIb)beta3 in native platelets than in liposomesJ Am Chem Soc2005127391691915656629
  • GonzalesPAPisitkunTHoffertJDLarge-scale proteomics and phosphoproteomics of urinary exosomesJ Am Soc Nephrol200920236337919056867
  • Gonzalez-BegneMLuBHanXProteomic analysis of human parotid gland exosomes by multidimensional protein identification technology (MudPIT)J Proteome Res2009831304131419199708
  • PisitkunTShenRFKnepperMAIdentification and proteomic profiling of exosomes in human urineProc Natl Acad Sci U S A200410136133681337315326289
  • LoozeCYuiDLeungLProteomic profiling of human plasma exosomes identifies PPARgamma as an exosome-associated proteinBiochem Biophys Res Commun2009378343343819028452
  • BardMPHegmansJPHemmesAProteomic analysis of exosomes isolated from human malignant pleural effusionsAm J Respir Cell Mol Biol200431111412114975938
  • MathivananSLimJWTauroBJJiHMoritzRLSimpsonRJProteomics analysis of A33 immunoaffinity-purified exosomes released from the human colon tumor cell line LIM1215 reveals a tissue-specific protein signatureMol Cell Proteomics20109219720819837982
  • JohnASRothmanVLTuszynskiGPThrombospondin-1 (TSP-1) stimulates expression of integrin alpha6 in human breast carcinoma cells: a downstream modulator of TSP-1-induced cellular adhesionJ Oncol2010201064537620631908
  • NuceraCPorrelloAAntonelloZAB-Raf(V600E) and thrombospondin-1 promote thyroid cancer progressionProc Natl Acad Sci U S A201010723106491065420498063
  • Rivera-FillatMPReigFMartinezEMGrau-OlieteMRImproved therapeutic responses for liposomal doxorubicin targeted via thrombospondin peptidomimetics versus untargeted doxorubicinJ Pept Sci201016731532120552567
  • KazerounianSYeeKOLawlerJThrombospondins in cancerCell Mol Life Sci200865570071218193162
  • ZhangXLawlerJThrombospondin-based antiangiogenic therapyMicrovasc Res2007742–3909917559888
  • SkokosDLe PanseSVillaIMast cell-dependent B and T lymphocyte activation is mediated by the secretion of immunologically active exosomesJ Immunol2001166286887611145662
  • SkokosDLe PanseSVillaINonspecific B and T cell-stimulatory activity mediated by mast cells is associated with exosomesInt Arch Allergy Immunol20011241–313313611306949
  • BuschowSIvan BalkomBWAalbertsMHeckAJWaubenMStoorvogelWMHC class II-associated proteins in B-cell exosomes and potential functional implications for exosome biogenesisImmunol Cell Biol201088885185620458337
  • LongEOICAM-1: getting a grip on leukocyte adhesionJ Immunol201118695021502321505213
  • SvajgerUAnderluhMJerasMObermajerNC-type lectin DC-SIGN: an adhesion, signalling and antigen-uptake molecule that guides dendritic cells in immunityCell Signal201022101397140520363321
  • SeguraENiccoCLombardBICAM-1 on exosomes from mature dendritic cells is critical for efficient naive T-cell primingBlood2005106121622315790784
  • SeguraEGuerinCHoggNAmigorenaSTheryCCD8+ dendritic cells use LFA-1 to capture MHC-peptide complexes from exosomes in vivoJ Immunol200717931489149617641014
  • ChoiDSLeeJMParkGWProteomic analysis of microvesicles derived from human colorectal cancer cellsJ Proteome Res20076124646465517956143
  • KesimerMScullMBrightonBCharacterization of exosome-like vesicles released from human tracheobronchial ciliated epithelium: a possible role in innate defenseFASEB J20092361858186819190083
  • BrodbeckWGMoldCAtkinsonJPMedofMECooperation between decay-accelerating factor and membrane cofactor protein in protecting cells from autologous complement attackJ Immunol200016573999400611034410
  • RollinsSASimsPJThe complement-inhibitory activity of CD59 resides in its capacity to block incorporation of C9 into membrane C5b-9J Immunol19901449347834831691760
  • LiuSIshidaTKiwadaHCharacterization of bovine serum factor triggering the lysis of liposomes via complement activationBiol Pharm Bull19982143903979586579
  • BradleyAJDevineDVAnsellSMJanzenJBrooksDEInhibition of liposome-induced complement activation by incorporated poly(ethylene glycol)-lipidsArch Biochem Biophys199835721851949735159
  • FevrierBViletteDArcherFCells release prions in association with exosomesProc Natl Acad Sci U S A2004101269683968815210972
  • PotolicchioICarvenGJXuXProteomic analysis of microglia-derived exosomes: metabolic role of the aminopeptidase CD13 in neuropeptide catabolismJ Immunol200517542237224316081791
  • JiHErfaniNTauroBJDifference gel electrophoresis analysis of Ras-transformed fibroblast cell-derived exosomesElectrophoresis200829122660267118494037
  • AndersenMHGraversenHFedosovSNPetersenTERasmussenJTFunctional analyses of two cellular binding domains of bovine lactadherinBiochemistry200039206200620610821695
  • LinLHuaiQHuangMFurieBFurieBCCrystal structure of the bovine lactadherin C2 domain, a membrane binding motif, shows similarity to the C2 domains of factor V and factor VIIIJ Mol Biol2007371371772417583728
  • MorelliAELarreginaATShufeskyWJEndocytosis, intracellular sorting, and processing of exosomes by dendritic cellsBlood2004104103257326615284116
  • FensMHMastrobattistaEde GraaffAMAngiogenic endothelium shows lactadherin-dependent phagocytosis of aged erythrocytes and apoptotic cellsBlood200811194542455018292292
  • QiangXLiJWuRExpression and characterization of recombinant human milk fat globule-EGF factor VIIIInt J Mol Med20112861071107621874225
  • ShenBWuNYangJMGouldSJProtein targeting to exosomes/microvesicles by plasma membrane anchorsJ Biol Chem201128616143831439521300796
  • KlammtCSchwarzDLohrFSchneiderBDotschVBernhardFCell-free expression as an emerging technique for the large scale production of integral membrane proteinFEBS J2006273184141415316930130
  • ReckelSSobhanifarSDurstFStrategies for the cell-free expression of membrane proteinsMethods Mol Biol201060718721220204858
  • SchwarzDDotschVBernhardFProduction of membrane proteins using cell-free expression systemsProteomics20088193933394618763710
  • HovijitraNTWuuJJPeakerBSwartzJRCell-free synthesis of functional aquaporin Z in synthetic liposomesBiotechnol Bioeng20091041404919557835
  • KanedaMNomuraSMIchinoseSDirect formation of proteoliposomes by in vitro synthesis and cellular cytosolic delivery with connexin-expressing liposomesBiomaterials20093023–243971397719423159
  • MalamYLoizidouMSeifalianAMLiposomes and nanoparticles: nanosized vehicles for drug delivery in cancerTrends Pharmacol Sci2009301159259919837467
  • TarahovskyYS“Smart” liposomal nanocontainers in biology and medicineBiochemistry (Mosc)201075781182420673204
  • WangHXKolesnikovaTVDenisonCGygiSPHemlerMEThe C-terminal tail of tetraspanin protein CD9 contributes to its function and molecular organizationJ Cell Sci2011124Pt 162702271021771881
  • BartelsCLTsongalisGJMicroRNAs: novel biomarkers for human cancerClin Chem200955462363119246618
  • HenryJCAzevedo-PoulyACSchmittgenTDmicroRNA replacement therapy for cancerPharm Res201128123030304221879389
  • KotaJChivukulaRRO’DonnellKATherapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer modelCell200913761005101719524505
  • LiuCKelnarKLiuBThe microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44Nat Med201117221121521240262
  • GambariRFabbriEBorgattiMTargeting microRNAs involved in human diseases: a novel approach for modification of gene expression and drug developmentBiochem Pharmacol201182101416142921864506
  • KotaSKBalasubramanianSCancer therapy via modulation of micro RNA levels: a promising futureDrug Discov Today20101517–1873374020692360
  • MatsubaraHTakeuchiTNishikawaEApoptosis induction by antisense oligonucleotides against miR-17-15p and miR-20a in lung cancers overexpressing miR-17–92Oncogene200726416099610517384677
  • SeguraMFHannifordDMenendezSAberrant miR-182 expression promotes melanoma metastasis by repressing FOXO3 and microphthalmia-associated transcription factorProc Natl Acad Sci U S A200910661814181919188590
  • SiMLZhuSWuHLuZWuFMoYYmiR-21-mediated tumor growthOncogene200726192799280317072344
  • SylvestreYDe GuireVQueridoEAn E2F/miR-20a autoregulatory feedback loopJ Biol Chem200728242135214317135249
  • LuYRoySNuovoGAnti-microRNA-222 (anti-miR-222) and -181B suppress growth of tamoxifen-resistant xenografts in mouse by targeting TIMP3 protein and modulating mitogenic signalJ Biol Chem201128649422924230222009755
  • YangYPChienYChiouGYInhibition of cancer stem cell-like properties and reduced chemoradioresistance of glioblastoma using microRNA145 with cationic polyurethane-short branch PEIBiomaterials20123351462147622098779
  • XuDTakeshitaFHinoYmiR-22 represses cancer progression by inducing cellular senescenceJ Cell Biol2011193240942421502362
  • KimDHRossiJJStrategies for silencing human disease using RNA interferenceNat Rev Genet20078317318417304245
  • GuoPCobanOSneadNMEngineering RNA for targeted siRNA delivery and medical applicationAdv Drug Deliv Rev201062665066620230868
  • SzokaFMolecular biology. The art of assemblyScience2008319586357857918239114
  • LakhalSWoodMJExosome nanotechnology: an emerging paradigm shift in drug delivery: exploitation of exosome nanovesicles for systemic in vivo delivery of RNAi heralds new horizons for drug delivery across biological barriersBioessays2011331073774121932222